StockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)

StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX) in a research report sent to investors on Tuesday. The firm issued a hold rating on the software maker’s stock.

A number of other brokerages have also commented on MDRX. Royal Bank of Canada cut their target price on Veradigm from $22.00 to $11.00 and set an outperform rating for the company in a research note on Friday, January 19th. Barclays assumed coverage on shares of Veradigm in a report on Wednesday, January 3rd. They set an equal weight rating and a $11.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft reissued a hold rating and issued a $10.00 price target (down previously from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of Hold and a consensus target price of $11.25.

Veradigm Stock Up 3.5 %

Veradigm stock opened at $7.95 on Tuesday. The business has a 50 day moving average price of $7.77 and a two-hundred day moving average price of $9.99. Veradigm has a 12 month low of $5.01 and a 12 month high of $14.09.

Hedge Funds Weigh In On Veradigm

Institutional investors have recently bought and sold shares of the business. TFO Wealth Partners LLC increased its stake in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after buying an additional 5,264 shares in the last quarter. Gladius Capital Management LP grew its holdings in Veradigm by 135.0% during the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after acquiring an additional 3,587 shares during the last quarter. Headlands Technologies LLC increased its position in Veradigm by 14,907.7% in the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock valued at $102,000 after acquiring an additional 9,690 shares in the last quarter. Covestor Ltd raised its stake in shares of Veradigm by 10.3% in the third quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after acquiring an additional 966 shares during the last quarter. Finally, Meadow Creek Wealth Advisors LLC acquired a new position in shares of Veradigm during the first quarter worth approximately $83,000.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.